Exact Sciences Schedules Third Quarter 2024 Earnings Call
Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, has announced its plans to release third quarter 2024 financial results after the close of U.S. financial markets on November 5, 2024. Following the release, the company will host a webcast and conference call at 5 p.m. ET to discuss financial results and business progress.
The live webcast can be accessed at www.exactsciences.com. For telephone access, domestic callers should dial 888-330-2384, while international callers should dial +1 240-789-2701. The access code for both is 4437608. A replay of the webcast will be available on the company's website. The event is open to all interested parties.
Exact Sciences Corp. (Nasdaq: EXAS), un fornitore leader di test per la diagnosi e lo screening del cancro, ha annunciato i suoi piani per pubblicare i risultati finanziari del terzo trimestre 2024 dopo la chiusura dei mercati finanziari statunitensi il 5 novembre 2024. Dopo la pubblicazione, l'azienda ospiterà un webcast e una teleconferenza alle 17:00 ET per discutere i risultati finanziari e i progressi aziendali.
Il webcast dal vivo sarà accessibile su www.exactsciences.com. Per l'accesso telefonico, i chiamanti nazionali devono comporre il 888-330-2384, mentre i chiamanti internazionali devono comporre il +1 240-789-2701. Il codice di accesso per entrambi è 4437608. Una registrazione del webcast sarà disponibile sul sito web dell'azienda. L'evento è aperto a tutte le parti interessate.
Exact Sciences Corp. (Nasdaq: EXAS), un proveedor líder de pruebas de diagnóstico y detección de cáncer, ha anunciado sus planes de publicar los resultados financieros del tercer trimestre de 2024 después del cierre de los mercados financieros de EE. UU. el 5 de noviembre de 2024. Después de la publicación, la empresa llevará a cabo un webcast y una conferencia telefónica a las 5 p.m. ET para discutir los resultados financieros y el progreso empresarial.
El webcast en vivo se puede acceder en www.exactsciences.com. Para el acceso telefónico, los llamantes nacionales deben marcar el 888-330-2384, mientras que los llamantes internacionales deben marcar el +1 240-789-2701. El código de acceso para ambos es 4437608. Una repetición del webcast estará disponible en el sitio web de la empresa. El evento está abierto a todas las partes interesadas.
엑잇 사이언스 주식회사 (Nasdaq: EXAS), 암 스크리닝 및 진단 검사의 선도적인 공급업체는 2024년 3분기 재무 결과를 2024년 11월 5일 미국 금융 시장 종료 후에 발표할 계획이라고 발표했습니다. 발표 후 회사는 재무 결과 및 사업 진행 상황에 대해 논의하기 위해 동부 표준시 기준 오후 5시에 웹캐스트 및 컨퍼런스 콜을 개최할 것입니다.
실시간 웹캐스트는 www.exactsciences.com에서 접근할 수 있습니다. 전화 접근 시, 국내 전화자는 888-330-2384로 걸어야 하며, 국제 전화자는 +1 240-789-2701로 걸어야 합니다. 두 번호 모두의 접근 코드 는 4437608입니다. 웹캐스트 재생본은 회사 웹사이트에서 제공될 것입니다. 이 행사는 모든 이해 관계자에게 열려 있습니다.
Exact Sciences Corp. (Nasdaq: EXAS), un fournisseur de premier plan de tests de dépistage et de diagnostic du cancer, a annoncé ses plans pour publier les résultats financiers du troisième trimestre 2024 après la clôture des marchés financiers américains le 5 novembre 2024. Après cette publication, l'entreprise organisera un webinaire et une conférence téléphonique à 17h00 ET pour discuter des résultats financiers et des progrès de l'entreprise.
Le webinaire en direct sera accessible sur www.exactsciences.com. Pour l'accès téléphonique, les appelants nationaux doivent composer le 888-330-2384, tandis que les appelants internationaux doivent composer le +1 240-789-2701. Le code d'accès pour les deux est 4437608. Un enregistrement du webinaire sera disponible sur le site de l'entreprise. L'événement est ouvert à toutes les parties intéressées.
Exact Sciences Corp. (Nasdaq: EXAS), ein führender Anbieter von Krebs-Screening- und Diagnosetests, hat angekündigt, dass die Finanzergebnisse für das dritte Quartal 2024 nach dem Handelsende der US-Finanzmärkte am 5. November 2024 veröffentlicht werden. Nach der Veröffentlichung wird das Unternehmen um 17:00 Uhr ET einen Webcast und eine Telefonkonferenz abhalten, um die Finanzergebnisse und den Geschäftsfortschritt zu diskutieren.
Der Live-Webcast kann unter www.exactsciences.com abgerufen werden. Für den telefonischen Zugang sollten nationale Anrufer 888-330-2384 wählen, während internationale Anrufer +1 240-789-2701 wählen sollten. Der Zugangscode für beide lautet 4437608. Eine Wiederholung des Webcasts wird auf der Website des Unternehmens verfügbar sein. Die Veranstaltung ist für alle Interessierten geöffnet.
- None.
- None.
| Third quarter 2024 webcast & conference call details | |||
|
|||
Date: |
Tuesday, November 5, 2024 |
||
Time: |
5 p.m. ET |
||
Webcast: |
The live webcast can be accessed at www.exactsciences.com |
||
Telephone: |
Domestic callers, dial 888-330-2384 |
||
|
International callers, dial +1 240-789-2701 |
||
|
Access code for both domestic and international callers: 4437608 |
||
A replay of the webcast will be available at www.exactsciences.com. The webcast, conference call, and replay are open to all interested parties.
About Exact Sciences Corp.
A leading provider of cancer screening and diagnostic tests, Exact Sciences gives patients and health care professionals the clarity needed to take life-changing action earlier. Building on the success of the Cologuard® and Oncotype® tests, Exact Sciences is investing in its pipeline to develop innovative solutions for use before, during, and after a cancer diagnosis. For more information, visit ExactSciences.com, follow Exact Sciences on X @ExactSciences, or find Exact Sciences on LinkedIn and Facebook.
View source version on businesswire.com: https://www.businesswire.com/news/home/20241008746549/en/
Erik Holznecht
Exact Sciences Corp.
investorrelations@exactsciences.com
608-800-6605
Source: Exact Sciences Corp.
FAQ
When will Exact Sciences (EXAS) release its Q3 2024 earnings?
What time is Exact Sciences' (EXAS) Q3 2024 earnings call?
How can I access Exact Sciences' (EXAS) Q3 2024 earnings webcast?
What are the dial-in numbers for Exact Sciences' (EXAS) Q3 2024 earnings call?
